Drawing for CHIVD CHEMCLIN DIAGNOSTICS CORPORATION

USPTO serial 90265690

CHIVD CHEMCLIN DIAGNOSTICS CORPORATION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
JAGANNATHAN, SIDDHARTH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CHIVD CHEMCLIN DIAGNOSTICS CORPORATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leo M. Loughlin

Leo M. Loughlin ROTHWELL, FIGG, ERNST & MANBECK, PC901 New York Avenue, N.W.Suite 900 EastWASHINGTON, DC 20001

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Diagnostic reagents and contrast media for medical use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic reagents for medicinal use; Diagnostic preparations for medical or veterinary purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic reagents; Reagents and media for medical and veterinary diagnostic purposes; Pharmaceutical preparations for medical purposes for detecting the presence of cardiac, inflammation, fertility, infectious diseases, thyroid, tumor markers, diabetes, TORCHACTIVE—
010Medical devices for use in treating or diagnosing thyroid disease, reproductive disease, infectious disease, autoimmune disease, tumor disease, cardiovascular disease, bone metabolic disease, diabetes and hepatic fibrosis; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Hematology analyzers for medical diagnostic uses; Medical diagnostic apparatus for detecting cancer; Diagnostic apparatus for the detection of cancer; Medical instrument for cardiovascular diagnostics; Medical diagnostic instruments for the analysis of body fluids; Medical diagnostic apparatus for testing DNA, protein, Antigen, antibody, whole blood, serum and plasma; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; Medical apparatus and instruments for detecting the presence of cardiac, inflammation, fertility, infectious diseases, thyroid, tumor markers, diabetes, TORCHACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 4, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 4, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 24, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 22, 2023EX4GSOU EXTENSION 4 GRANTED—
May 22, 2023EXT4SOU EXTENSION 4 FILED—
May 22, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 20, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 18, 2023EX3GSOU EXTENSION 3 GRANTED—
Jan 18, 2023EXT3SOU EXTENSION 3 FILED—
Jan 18, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 19, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 15, 2022EX2GSOU EXTENSION 2 GRANTED—
Jul 15, 2022EXT2SOU EXTENSION 2 FILED—
Jul 15, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 21, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 19, 2022EX1GSOU EXTENSION 1 GRANTED—
Jan 19, 2022EXT1SOU EXTENSION 1 FILED—
Jan 19, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 27, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 1, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 1, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 12, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 26, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Apr 26, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 26, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 26, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 24, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2021DOCKASSIGNED TO EXAMINER—
Dec 9, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 8, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance